Literature DB >> 23700233

Progressive multifocal leukoencephalopathy (PML) associated with HIV Clade C--is not uncommon.

M Netravathi1, Anita Mahadevan, Parthasarathy Satishchandra, N Shobha, Pooja Mailankody, Thennarasu Kandavel, Saini Jitender, G Anantaram, S Nagarathna, S Govekar, B V Ravikumar, V Ravi, S K Shankar.   

Abstract

Progressive multifocal leukoencephalopathy (PML) is a rare, subacute, demyelinating disease of the central nervous system caused by JC virus. Studies of PML from HIV Clade C prevalent countries are scarce. We sought to study the clinical, neuroimaging, and pathological features of PML in HIV Clade C patients from India. This is a prospective cum retrospective study, conducted in a tertiary care Neurological referral center in India from Jan 2001 to May 2012. Diagnosis was considered "definite" (confirmed by histopathology or JCV PCR in CSF) or "probable" (confirmed by MRI brain). Fifty-five patients of PML were diagnosed between January 2001 and May 2012. Complete data was available in 38 patients [mean age 39 ± 8.9 years; duration of illness-82.1 ± 74.7 days). PML was prevalent in 2.8 % of the HIV cohort seen in our Institute. Hemiparesis was the commonest symptom (44.7 %), followed by ataxia (36.8 %). Definitive diagnosis was possible in 20 cases. Eighteen remained "probable" wherein MRI revealed multifocal, symmetric lesions, hypointense on T1, and hyperintense on T2/FLAIR. Stereotactic biopsy (n = 11) revealed demyelination, enlarged oligodendrocytes with intranuclear inclusions and astrocytosis. Immunohistochemistry revelaed the presence of JC viral antigen within oligodendroglial nuclei and astrocytic cytoplasm. No differences in clinical, radiological, or pathological features were evident from PML associated with HIV Clade B. Clinical suspicion of PML was entertained in only half of the patients. Hence, a high index of suspicion is essential for diagnosis. There are no significant differences between clinical, radiological, and pathological picture of PML between Indian and Western countries.

Entities:  

Mesh:

Year:  2013        PMID: 23700233     DOI: 10.1007/s13365-013-0168-8

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  24 in total

1.  Genotypes of JC virus in East, Central and Southwest Europe.

Authors:  Hansjürgen T Agostini; Alison Deckhut; David V Jobes; Rosina Girones; Günther Schlunck; Marcin G Prost; Carolina Frias; E Pérez-Trallero; Caroline F Ryschkewitsch; Gerald L Stoner
Journal:  J Gen Virol       Date:  2001-05       Impact factor: 3.891

2.  Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy.

Authors:  Juan Berenguer; Pilar Miralles; Julio Arrizabalaga; Esteban Ribera; Fernando Dronda; Josu Baraia-Etxaburu; Pere Domingo; Manuel Márquez; Francisco J Rodriguez-Arrondo; Fernando Laguna; Rafael Rubio; José Lacruz Rodrigo; J Mallolas; Verónica de Miguel
Journal:  Clin Infect Dis       Date:  2003-04-02       Impact factor: 9.079

3.  Progressive multifocal leucoencephalopathy with discrete involvement of pyramidal tract.

Authors:  N Sobha; S Sinha; A B Taly; G R Arunodaya; S Ravishankar; B Anandh; A Mahadevan; V Santosh; S K Shankar
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-01       Impact factor: 10.154

4.  Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.

Authors:  Simona Bossolasco; Giliola Calori; Francesca Moretti; Antonio Boschini; Davide Bertelli; Maurizio Mena; Simonetta Gerevini; Arabella Bestetti; Rosa Pedale; Serena Sala; Stefania Sala; Adriano Lazzarin; Paola Cinque
Journal:  Clin Infect Dis       Date:  2005-02-01       Impact factor: 9.079

5.  JC virus-induced Progressive Multifocal Leukoencephalopathy.

Authors:  A Sami Saribas; Ahmet Ozdemir; Cathy Lam; Mahmut Safak
Journal:  Future Virol       Date:  2010-05       Impact factor: 1.831

Review 6.  The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology.

Authors:  Paola Cinque; Igor J Koralnik; David B Clifford
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

7.  Progressive multifocal leukoencephalopathy in patients with HIV infection.

Authors:  J R Berger; L Pall; D Lanska; M Whiteman
Journal:  J Neurovirol       Date:  1998-02       Impact factor: 2.643

Review 8.  Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases.

Authors:  J R Berger; B Kaszovitz; M J Post; G Dickinson
Journal:  Ann Intern Med       Date:  1987-07       Impact factor: 25.391

9.  Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India.

Authors:  Nagadenahalli B Siddappa; Prashanta K Dash; Anita Mahadevan; Narayana Jayasuryan; Fen Hu; Bethany Dice; Randy Keefe; Kadappa S Satish; Bhuthiah Satish; Kuttan Sreekanthan; Ramdas Chatterjee; Kandala Venu; Parthasarathy Satishchandra; Vasanthapuram Ravi; Susarla K Shankar; Raj Shankarappa; Udaykumar Ranga
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

10.  Reversible parkinsonism in a patient with progressive multifocal leucoencephalopathy.

Authors:  Caroline H Williams-Gray; Sani H Aliyu; Andrew M L Lever; Andrew F Dean; Graham G Lennox
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.